Tolerance to perioperative anemia. Mechanisms, influencing factors and limits

被引:0
作者
Habler, O.
Meier, J.
Pape, A.
Kertscho, H.
ZwiBler, B.
机构
[1] Krankenhaus Nordstadt GmbH, Operat Intensivmed & Schmerztherap, Anasthesiol Klin, D-60488 Frankfurt, Germany
[2] Klinikum Johann Wolfgang Goethe Univ, Operat Intensivmed & Schmerztherap, Anasthesiol Klin, Frankfurt, Germany
来源
ORTHOPADE | 2007年 / 36卷 / 08期
关键词
perioperative anemia; anemia tolerance; allogeneic transfusion; transfusion trigger;
D O I
10.1007/s00132-007-1126-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The expected cost explosion in transfusion medicine increases the socio- economic significance of specific institutional transfusion programs. In this context the estimated use of the patient's physiologic tolerance represents an integral part of any blood conservation concept. The present article summarizes the mechanisms, influencing factors and limits of this natural tolerance to anemia and deduces the indication for perioperative red blood cell transfusion. The current recommendations coincide to the effect that perioperative transfusion is unnecessary up to a Hb concentration of 10 g/dl ( 6.21 mmol/l) even in older patients with cardiopulmonary comorbidity and is only recommended in cases of Hb < 6 g/dl (< 3.72 mmol/l) in otherwise healthy subjects including pregnant women and children. Critically ill patients with multiple trauma and sepsis do not seem to benefit from transfusions up to Hb concentrations > 9 g/dl (> 5.59 mmol/l). In cases of massive hemorrhaging and diffuse bleeding disorders the maintenance of a Hb concentration of 10 g/dl (6.21 mmol/l) seems to contribute to stabilization of coagulation.
引用
收藏
页码:763 / 776
页数:14
相关论文
共 29 条
[1]  
Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198
[2]   Effect of anaemia and cardiovascular disease on surgical mortality and morbidity [J].
Carson, JL .
LANCET, 1996, 348 (9034) :1055-1060
[3]   Perioperative blood transfusion and postoperative mortality [J].
Carson, JL ;
Duff, A ;
Berlin, JA ;
Lawrence, VA ;
Poses, RM ;
Huber, EC ;
O'Hara, DA ;
Noveck, H ;
Strom, BL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (03) :199-205
[4]   OXYGEN-CONSUMPTION AND CARDIOVASCULAR FUNCTION IN CHILDREN DURING PROFOUND INTRAOPERATIVE NORMOVOLEMIC HEMODILUTION [J].
FONTANA, JL ;
WELBORN, L ;
MONGAN, PD ;
STURM, P ;
MARTIN, G ;
BUNGER, R .
ANESTHESIA AND ANALGESIA, 1995, 80 (02) :219-225
[5]   Transfusion medicine: looking to the future [J].
Goodnough, LT ;
Shander, A ;
Brecher, ME .
LANCET, 2003, 361 (9352) :161-169
[6]  
Habler O, 1997, Eur J Med Res, V2, P419
[7]   Artificial oxygen carriers as an alternative to red blood cell transfusion [J].
Habler, O ;
Pape, A ;
Meier, J ;
Zwissler, B .
ANAESTHESIST, 2005, 54 (08) :741-754
[8]   A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care [J].
Hébert, PC ;
Wells, G ;
Blajchman, MA ;
Marshall, J ;
Martin, C ;
Pagliarello, G ;
Tweeddale, M ;
Schweitzer, I ;
Yetisir, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :409-417
[9]  
Karger R, 2004, ANASTH INTENSIVMED, V45, P430
[10]   Cardiovascular response to acute normovolemic hemodilution in patients with coronary artery diseases: Assessment with transesophageal echocardiography [J].
Licker, M ;
Ellenberger, C ;
Sierra, J ;
Christenson, J ;
Diaper, J ;
Morel, D .
CRITICAL CARE MEDICINE, 2005, 33 (03) :591-597